A detailed history of Israel Englander (Millennium Management LLC) transactions in Biodesix Inc stock. As of the latest transaction made, Millennium Management LLC holds 165,342 shares of BDSX stock, worth $211,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares
165,342
Holding current value
$211,637
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.53 - $1.96 $252,973 - $324,070
165,342 New
165,342 $294,000
Q1 2024

May 15, 2024

BUY
$1.35 - $2.12 $12,737 - $20,002
9,435 Added 10.33%
100,755 $144,000
Q4 2023

Feb 14, 2024

BUY
$1.2 - $2.13 $109,584 - $194,511
91,320 New
91,320 $168,000
Q4 2022

Feb 14, 2023

SELL
$0.98 - $2.3 $10,054 - $23,597
-10,260 Reduced 8.69%
107,788 $248,000
Q3 2022

Nov 14, 2022

BUY
$1.24 - $2.89 $902 - $2,103
728 Added 0.62%
118,048 $150,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $51.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.